Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News

Texas stem cell provider under FDA gun 



October 18, 2012 - (Nature) - "On 1 October, a week after receiving the warning letter, Celltex attempted to defuse the news by announcing that it had received “a letter” (though Cellex didn’t reveal at that time that it was the relatively harsh “warning letter”). Noting disagreement with the FDA’s ruling that its processed cells need to be regulated as drugs, the company announced a “new clinical program” through which it planned to work with the FDA." Read Full Article


Posted on 13-Nov-12 by Gallerno, Jacob
Tags: Science and Industry News
Trackback Url  |  Link to this post | Bookmark this post with: